Regenxbio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.74

+0.77 (+7.72%)

As of Jun 25, 2:34 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target +72.1% upside

Low Target $13.35

Average Target $18.48

High Target $24.09

Current Price $10.74

Current
$10.74

Target
$18.48

$13.35 $18.48 avg $24.09

Scenario Analysis

Bear Case

$13.35

24.3%

Low target

Base Case

$18.48

+72.1%

Avg target

Bull Case

$24.09

+124.3%

High target

Risk/Reward

5.1x

Highly favorable

Price in Context

52-Week High

$16.19

-33.7% from high

52-Week Low

$5.46

+96.9% from low

Target vs 52W High

$18.48

+14.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%